Organisations are coming under an increasing amount of pressure to do business more sustainably. As a result, ESG (Environmental, Social, Governance) considerations are now a key part of companies’ strategic plans and roadmaps. At Ipsos we leverage research specialisms and cross-sector expertise to understand governments, businesses, and citizens to inform better decision making when it comes to all aspects of ESG.
Our world-leading experts produce primary data, research, and insights to fuel a healthy public debate and create value by providing a true understanding of society, markets, and people.
Discover a selection of Ipsos' finest pieces on ESG.
We give businesses, governments and public bodies the confidence they need to take the right actions for the benefit of people and the planet, to drive long-term prosperity for all.
Ipsos gives businesses, governments and public bodies the confidence they need to take the right actions for the benefit of people and the planet, to drive long-term prosperity for all. Discover how.
Ipsos gives businesses, governments and public bodies the confidence they need to take the right actions for the benefit of people and the planet, to drive long-term prosperity for all. Discover how.
Ipsos gives businesses, governments and public bodies the confidence they need to take the right actions for the benefit of people and the planet, to drive long-term prosperity for all. Discover how.
Ipsos gives businesses, governments and public bodies the confidence they need to take the right actions for the benefit of people and the planet, to drive long-term prosperity for all. Discover how.
Ipsos gives businesses, governments and public bodies the confidence they need to take the right actions for the benefit of people and the planet, to drive long-term prosperity for all. Discover how.
With several advanced therapy options now available to treat moderate-severe atopic dermatitis - and more on the horizon - how is the treatment landscape changing? Can we use evolutions in psoriasis treatment as a proxy, and can we draw any parallels between physicians’ therapeutic goals?
The dynamic, rapidly changing, consumer controlled environment demands that we rethink how we build brands, from a static approach to a dynamic, evolving philosophy.
